Details
Category: Volume 07 Issue 09 September 2019
Hits: 1004

Title: Improving Early Diagnosis of Cervical Cancer Lesions Using P16INK4a Biomarkers on Cellblocks from Cervical Smears

Authors: Martha W. M, Kyama M.C, Kibet P.S

 DOI: https://dx.doi.org/10.18535/jmscr/v7i9.64

Abstract

    

Universally, cancer of cervical is the second utmost regular malignant growth in females after cancer of breast. Timely recognition of pre-malignant lesions is an essential segment for the decrease of related morbidity and mortality. Though Pap test has been a helpful screening device, however hampered by high Intra and inter-observer changeability, false negatives at 20– 30% and false positives at 5– 70%. 

Objective:  The study determined the role of P16INK4a biomarker in the identification of low grade squamous intra-epithelial abrasions in cell blocks prepared from Pap smears and subsequently compared previous Pap results with colposcopy and cellblock results

Methods: This was a laboratory-based, prospective study with a parallel comparative arm at the Kenyatta National Hospital Reproductive health clinic (66). All patients who had abnormal Pap smear reports and referred for colposcopy, and consented for the study were enrolled. A smear was taken just before taking a colposcopy biopsy. The cytobrush was immediately put in Acid alcohol fixative centrifuged and deposits wrapped in a filter paper and processed histologically to form a cellblock. Colposcopy biopsies were then retrieved from the KNH histology lab and both samples subjected to Routine histological stain and eventually with biomarker P16. Total of 85 samples was collected.

Results:  There was a significant level of agreement between Pap smears and cellblock findings on the routine Histological stain. Of 58 cases analyzed Colposcopy had (39%) 27 negatives and (45%) 31 positives while cellblock had (48%) 33 negative and (36%) 25 positive for pre and malignancy with a confidence interval of 0.016 as the margin of error. Biomarker Colposcopy had (43%) 30 negativity and (41%) 28 positivity while cellblock had negativity of (46%) 32 and positivity of (38 %) 26. The specificity and sensitivity were based on the true values of colposcopy as the golden standard test for cervical cancer. Biomarker cellblock had the “sensitivity and specificity” of 93.3% and 93.8% respectively, while Haematoxyline and eosin-stained cellblock had sensitivity and specificity of 83.8% and 81.8% respectively.

Conclusion: Poor inter-rater agreement resulting to mortality and  morbidity associated with false positives and false negatives,  cellblock prepared from residues of cytobrush stained with haematoxyline and eosin and biomarker is likely to circumvent all the above,  together with minimizing loss to follow up as patients only visit health facility once and they acquire all the results without re-sampling hence drastically reducing the cost of colposcopy, which requires highly specialized equipment and experienced personnel who are very few and difficult to find.

References

  1. M. Parkin, “Global cancer statistics in the year 2000,” Lancet Oncology. 2001.
  2. P. et al., “Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening,” J. Natl. Cancer Inst., 2009.
  3. Pantanowitz, M. Hornish, and R. Goulart, “The impact of digital imaging in the field of cytopathology,” Cytojournal, 2009.
  4. B. Visioli et al., “hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy,” Br. J. Cancer, 2013.
  5. Safaeian, D. Solomon, and P. E. Castle, “Cervical Cancer Prevention-Cervical Screening: Science in Evolution,” Obstetrics and Gynecology Clinics of North America. 2007.
  6. Cristiani et al., “Rationale and development of an on-line quality assurance program for colposcopy in a population-based cervical screening setting in Italy," BMC Health Serv. Res., 2013.
  7. Li, M. J. Poi, and M. D. Tsai, “Regulatory mechanisms of tumor suppressor P16INK4A and their relevance to cancer,” Biochemistry, 2011.
  8. K. Ghosh et al., “Human papillomavirus testing for suspected cervical cancer patients from Southern Assam by fast-PCR.,” Asian Pac. J. Cancer Prev., 2011.
  9. B. Shidham, R. Mehrotra, G. Varsegi, K. D’Amore, B. Hunt, and R. Narayan, “P16 INK4a immunocytochemistry on cellblocks as an adjunct to cervical cytology: Potential reflex testing on specially prepared cellblocks from residual liquid-based cytology specimens,” Cytojournal, 2011.
  10. Burd, “Human papillomavirus and cervical cancerBurd E (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16: 1–17 Available at: http://www.sciencedirect.com/science/article/pii/S0140673607614160,” Clin Microbiol Rev, 2003.
  11. Castanon, R. Landy, and P. D. Sasieni, “Is cervical screening preventing adenoca-rcinoma and adenosquamous carcinoma of the cervix,” Int. J. Cancer, 2016.
  12. L. Wang et al., “P16INK4a and laminin-5γ2 chain expression during the progression of cervical neoplasia,” Acta Oncol. (Madr)., 2006.
  13. K.-E. et al., “Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis,” Int. J. Proteomics, 2014.
  14. Shrivastava, D. Barmon, P. Deka, and A. Kataki, “Vaginal vault carcinoma as second primary in a treated case of ovarian cancer,” J. Midlife. Health, 2012.
  15. Nishio et al., “P16INK4a immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: Comparison study with HPV genotyping,” J. Gynecol. Oncol., 2013.
  16. Klaes et al., “p16INK4a immunohisto-chemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia,” Am. J. Surg. Pathol., 2002.
  17. G. Kaspar and C. P. Crum, “The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders,” Arch. Pathol. Lab. Med., 2015.
  18. Q. Liu et al., “Increased RIPK4 expression is associated with progression and poor prognosis in cervical squamous cell carcinoma patients,” Sci. Rep., 2015.
  19. S. Aslani, A. Safaei, M. Pourjabali, and M. Momtahan, “Evaluation of Ki67, p16 and CK17 markers in differentiating cervical intraepithelial Neoplasia and benign lesions,” Iranian Journal of Medical Sciences. 2013.
  20. R. Nijhuis et al., “An overview of innovative techniques to improve cervical cancer screening,” Anal. Cell. Pathol., 2006.
  21. Rufforny, E. J. Wilkinson, R. Redman, N. A. Massoll, and C. Liu, “p16ink4a Is Helpful in Discriminating Between Cervical Intraepithelial Neoplasia 1 and Equivocal Lesions of the Cervix,” J. Low. Genit. Tract Dis., 2006.
  22. I. Tsoumpou et al., “p16INK4 aimmunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis,” Cancer Treatment Reviews. 2009.

Corresponding Author

Martha W. Maina